MetaCap

Phreesia (PHR) vs Repay (RPAY)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Repay (RPAY) has outperformed Phreesia (PHR) over the past year, gaining 21.2% versus a loss of 43.1%. Over five years, RPAY leads with a -77.6% price change compared with -81.0% for PHR. Phreesia is the larger company by market cap ($708.2 million vs $363.9 million), about 1.9 times the size.

On valuation, Repay trades at a lower forward P/E (3.9x vs 7.2x for Phreesia). Phreesia converts more of its revenue into profit, with a net margin of 0.5% versus -83.0%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

PHR-43.09%RPAY+21.20%
+56%-5%-65%
Nov 21, 20251 yearNov 20, 2026
PHR-83.19%RPAY-79.46%
+4%-44%-93%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

PHR versus RPAY key metrics
MetricPHRRPAY
Share price$11.41$3.83
Market cap$708.23M$363.92M
1-day change-3.88%-4.49%
YTD return-32.57%+4.93%
1-year return-43.09%+21.20%
5-year return-80.97%-77.62%
P/E ratio (TTM)67.12—
Forward P/E7.233.88
EPS (TTM)$0.17$-2.02
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$480.59M$309.26M
Revenue growth (YoY)+14.48%-1.21%
Net income (latest FY)$2.31M$-256.72M
Gross margin85.15%75.02%
Operating margin-1.38%-82.36%
Net margin0.48%-83.01%
52-week high$21.24$4.81
52-week low$7.77$2.30
Distance from 52-week high-46.28%-20.29%
Analyst consensusbuybuy
Avg. price target upside+21.56%+68.67%
Average volume686.47K439.34K
Shares outstanding62.07M89.73M
Employees1,789486
SectorConsumer DiscretionaryConsumer Discretionary
IndustryBusiness ServicesBusiness Services

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • RPAY has outperformed PHR by 64.3 percentage points over the past year.
  • Phreesia is more profitable, keeping 0.5 cents of every revenue dollar as net income versus -83.0 cents for Repay.
  • Phreesia grew revenue faster in its latest fiscal year (+14.48% vs -1.21%).

About Phreesia

PHR stock →

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada.

Consumer Discretionary · Business Services · 1,789 employees

About Repay

RPAY stock →

Repay Holdings Corporation, a payments technology company, provides integrated payment processing solutions that enables consumers and businesses to make payments using electronic payment methods in the United States. It operates through two segments: Consumer Payments and Business Payments.

Consumer Discretionary · Business Services · 486 employees

PHR vs RPAY FAQ

Which is bigger, Phreesia or Repay?

Phreesia (PHR) is larger, with a market capitalization of $708.23M compared with $363.92M for Repay (RPAY).

Which stock has performed better over the past year, PHR or RPAY?

RPAY returned +21.20% over the past 12 months, compared with -43.09% for PHR (price return, excluding dividends). Past performance does not predict future results.

Are Phreesia and Repay in the same industry?

Yes. Both are classified in the Business Services industry within the Consumer Discretionary sector.

More comparisons